Glenmede Trust CO Na Incyte Corp Transaction History

Glenmede Trust CO Na

$19.1 Billion
Q4 2024

A detailed history of Glenmede Trust CO Na transactions in Incyte Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 636,970 shares of INCY stock, worth $46.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

636,970

Previous 697,025 8.62%

Holding current value

$46.8 Million

Previous $46.1 Million 4.51%

% of portfolio

0.23%

Previous 0.22%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$65.08 - $83.38 $3.91 Million - $5.01 Million	-60,055 Reduced 8.62%	636,970 $44 Million
Q3 2024 Nov 13, 2024	SELL	$57.33 - $68.61 $9 Million - $10.8 Million	-156,962 Reduced 18.38%	697,025 $46.1 Million
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $43.7 Million - $54.4 Million	853,987 New	853,987 $51.8 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $101,409 - $122,711	-1,256 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $7,060 - $9,104	83 Added 7.08%	1,256 $112,000
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $17,061 - $25,053	230 Added 24.39%	1,173 $121,000
Q4 2019 Feb 12, 2020	SELL	$73.04 - $95.72 $20,378 - $26,705	-279 Reduced 22.83%	943 $82,000
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $12,498 - $15,079	170 Added 16.16%	1,222 $103,000
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $24,979 - $34,650	393 Added 59.64%	1,052 $89,000
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $38,551 - $46,090	659 New	659 $41,000
Q3 2018 Nov 15, 2018	SELL	$61.75 - $74.23 $30,936 - $37,189	-501 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$60.85 - $83.98 $1,460 - $2,015	24 Added 5.03%	501 $34,000
Q4 2017 Feb 15, 2018	SELL	$93.56 - $116.6 $19,647 - $24,486	-210 Reduced 30.57%	477 $45,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $74,986 - $94,991	687	687 $0

Others Institutions Holding INCY

# of Institutions

708

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Incyte Corp Transaction History